Do analysts recommend DYNT or IVF?

INVO Fertility has a consensus price target of $20.00, indicating a potential upside of 716.33%. Given INVO Fertility's stronger consensus rating and higher probable upside, analysts clearly believe INVO Fertility is more favorable than Dynatronics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 INVO Fertility 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has preferable valuation & earnings, DYNT or IVF?

Dynatronics has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dynatronics $33.60M 0.00 -$2.70M -$1.35 N/A INVO Fertility $6.84M 0.64 -$25.13M -$1.85 thousand N/A

Do analysts rate BBLG or DYNT?

Given Dynatronics' higher probable upside, analysts plainly believe Dynatronics is more favorable than Bone Biologics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bone Biologics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts prefer GCTK or DYNT?

Given Dynatronics' higher probable upside, analysts clearly believe Dynatronics is more favorable than GlucoTrack. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GlucoTrack 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is GCTK or DYNT more profitable?

GlucoTrack has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat GlucoTrack's return on equity. Company Net Margins Return on Equity Return on Assets GlucoTrack N/A -581.98% -220.10% Dynatronics -8.35% -41.81% -9.56%

Do analysts rate DYNT or PTHL?

Given Dynatronics' higher probable upside, research analysts clearly believe Dynatronics is more favorable than Pheton. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Pheton 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, DYNT or PTHL?

Pheton has lower revenue, but higher earnings than Dynatronics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dynatronics $33.60M 0.00 -$2.70M -$1.35 N/A Pheton $305.22K 6.69 -$660K N/A N/A

Is DYNT or PTHL more profitable?

Pheton has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Pheton's return on equity of 0.00% beat Dynatronics' return on equity. Company Net Margins Return on Equity Return on Assets Dynatronics -8.35% -41.81% -9.56% Pheton N/A N/A N/A

Do analysts recommend DYNT or VBIO?

Given Dynatronics' higher probable upside, analysts clearly believe Dynatronics is more favorable than Valion Bio, Inc. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Valion Bio, Inc. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Dynatronics (DYNT) Competitors

Compare

DYNT vs. IVF, BBLG, GCTK, PTHL, and VBIO

Should you buy Dynatronics stock or one of its competitors? MarketBeat compares Dynatronics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Dynatronics include INVO Fertility (IVF), Bone Biologics (BBLG), GlucoTrack (GCTK), Pheton (PTHL), and Valion Bio, Inc. Common Stock (VBIO). These companies are all part of the "medical equipment" industry.

How does Dynatronics compare to INVO Fertility?

Dynatronics (NASDAQ:DYNT) and INVO Fertility (NASDAQ:IVF) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

In the previous week, INVO Fertility had 5 more articles in the media than Dynatronics. MarketBeat recorded 5 mentions for INVO Fertility and 0 mentions for Dynatronics. INVO Fertility's average media sentiment score of 0.99 beat Dynatronics' score of 0.00 indicating that INVO Fertility is being referred to more favorably in the news media.

Company	Overall Sentiment
Dynatronics	Neutral
INVO Fertility	Positive

Dynatronics has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A
INVO Fertility	$6.84M	0.64	-$25.13M	-$1.85 thousand	N/A

INVO Fertility has a consensus price target of $20.00, indicating a potential upside of 716.33%. Given INVO Fertility's stronger consensus rating and higher probable upside, analysts clearly believe INVO Fertility is more favorable than Dynatronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Dynatronics has a net margin of -8.35% compared to INVO Fertility's net margin of -183.75%. Dynatronics' return on equity of -41.81% beat INVO Fertility's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dynatronics	-8.35%	-41.81%	-9.56%
INVO Fertility	-183.75%	-420.62%	-45.21%

4.2% of Dynatronics shares are held by institutional investors. Comparatively, 12.0% of INVO Fertility shares are held by institutional investors. 2.9% of Dynatronics shares are held by insiders. Comparatively, 0.7% of INVO Fertility shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Dynatronics has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market. Comparatively, INVO Fertility has a beta of 2.33, meaning that its share price is 133% more volatile than the broader market.

Summary

INVO Fertility beats Dynatronics on 8 of the 15 factors compared between the two stocks.

How does Dynatronics compare to Bone Biologics?

Bone Biologics (NASDAQ:BBLG) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation and dividends.

34.3% of Bone Biologics shares are held by institutional investors. Comparatively, 4.2% of Dynatronics shares are held by institutional investors. 6.1% of Bone Biologics shares are held by insiders. Comparatively, 2.9% of Dynatronics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Bone Biologics had 1 more articles in the media than Dynatronics. MarketBeat recorded 1 mentions for Bone Biologics and 0 mentions for Dynatronics. Bone Biologics' average media sentiment score of 1.87 beat Dynatronics' score of 0.00 indicating that Bone Biologics is being referred to more favorably in the media.

Company	Overall Sentiment
Bone Biologics	Very Positive
Dynatronics	Neutral

Bone Biologics has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat Bone Biologics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bone Biologics	N/A	-50.47%	-47.40%
Dynatronics	-8.35%	-41.81%	-9.56%

Dynatronics has higher revenue and earnings than Bone Biologics. Bone Biologics is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bone Biologics	N/A	N/A	-$3.11M	-$2.27	N/A
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A

Bone Biologics has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market. Comparatively, Dynatronics has a beta of 0.31, indicating that its share price is 69% less volatile than the broader market.

Given Dynatronics' higher probable upside, analysts plainly believe Dynatronics is more favorable than Bone Biologics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bone Biologics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Bone Biologics and Dynatronics tied by winning 7 of the 14 factors compared between the two stocks.

How does Dynatronics compare to GlucoTrack?

GlucoTrack (NASDAQ:GCTK) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation and earnings.

10.9% of GlucoTrack shares are owned by institutional investors. Comparatively, 4.2% of Dynatronics shares are owned by institutional investors. 2.2% of GlucoTrack shares are owned by company insiders. Comparatively, 2.9% of Dynatronics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Dynatronics has higher revenue and earnings than GlucoTrack. GlucoTrack is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GlucoTrack	N/A	N/A	-$19.39M	-$18.04	N/A
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A

GlucoTrack has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market. Comparatively, Dynatronics has a beta of 0.31, suggesting that its stock price is 69% less volatile than the broader market.

GlucoTrack has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat GlucoTrack's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GlucoTrack	N/A	-581.98%	-220.10%
Dynatronics	-8.35%	-41.81%	-9.56%

Given Dynatronics' higher probable upside, analysts clearly believe Dynatronics is more favorable than GlucoTrack.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GlucoTrack	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, GlucoTrack had 1 more articles in the media than Dynatronics. MarketBeat recorded 1 mentions for GlucoTrack and 0 mentions for Dynatronics. GlucoTrack's average media sentiment score of 1.87 beat Dynatronics' score of 0.00 indicating that GlucoTrack is being referred to more favorably in the media.

Company	Overall Sentiment
GlucoTrack	Very Positive
Dynatronics	Neutral

Summary

Dynatronics beats GlucoTrack on 8 of the 14 factors compared between the two stocks.

How does Dynatronics compare to Pheton?

Dynatronics (NASDAQ:DYNT) and Pheton (NASDAQ:PTHL) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.

Given Dynatronics' higher probable upside, research analysts clearly believe Dynatronics is more favorable than Pheton.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Pheton	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Dynatronics' average media sentiment score of 0.00 equaled Pheton'saverage media sentiment score.

Company	Overall Sentiment
Dynatronics	Neutral
Pheton	Neutral

4.2% of Dynatronics shares are held by institutional investors. 2.9% of Dynatronics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Dynatronics has a beta of 0.31, indicating that its share price is 69% less volatile than the broader market. Comparatively, Pheton has a beta of 5.4, indicating that its share price is 440% more volatile than the broader market.

Pheton has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Pheton's return on equity of 0.00% beat Dynatronics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dynatronics	-8.35%	-41.81%	-9.56%
Pheton	N/A	N/A	N/A

Pheton has lower revenue, but higher earnings than Dynatronics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A
Pheton	$305.22K	6.69	-$660K	N/A	N/A

Summary

Pheton beats Dynatronics on 6 of the 10 factors compared between the two stocks.

How does Dynatronics compare to Valion Bio, Inc. Common Stock?

Dynatronics (NASDAQ:DYNT) and Valion Bio, Inc. Common Stock (NASDAQ:VBIO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.

In the previous week, Valion Bio, Inc. Common Stock had 5 more articles in the media than Dynatronics. MarketBeat recorded 5 mentions for Valion Bio, Inc. Common Stock and 0 mentions for Dynatronics. Valion Bio, Inc. Common Stock's average media sentiment score of 0.31 beat Dynatronics' score of 0.00 indicating that Valion Bio, Inc. Common Stock is being referred to more favorably in the news media.

Company	Overall Sentiment
Dynatronics	Neutral
Valion Bio, Inc. Common Stock	Neutral

Given Dynatronics' higher probable upside, analysts clearly believe Dynatronics is more favorable than Valion Bio, Inc. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Valion Bio, Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Dynatronics has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market. Comparatively, Valion Bio, Inc. Common Stock has a beta of 1.79, meaning that its share price is 79% more volatile than the broader market.

Valion Bio, Inc. Common Stock has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat Valion Bio, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dynatronics	-8.35%	-41.81%	-9.56%
Valion Bio, Inc. Common Stock	N/A	-138.10%	-63.67%

4.2% of Dynatronics shares are held by institutional investors. Comparatively, 4.3% of Valion Bio, Inc. Common Stock shares are held by institutional investors. 2.9% of Dynatronics shares are held by company insiders. Comparatively, 2.2% of Valion Bio, Inc. Common Stock shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Dynatronics has higher revenue and earnings than Valion Bio, Inc. Common Stock. Valion Bio, Inc. Common Stock is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A
Valion Bio, Inc. Common Stock	$780K	2.28	-$8.88M	-$6.68	N/A

Summary

Dynatronics beats Valion Bio, Inc. Common Stock on 8 of the 14 factors compared between the two stocks.

Get Dynatronics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DYNT vs. The Competition

Export

Metric	Dynatronics	Surgical & medical instruments Industry	Medical Sector	NASDAQ Exchange
Market Cap	$653K	$40.79M	$6.70B	$12.22B
Dividend Yield	N/A	1.08%	2.67%	6.12%
P/E Ratio	-0.01	19.40	25.76	24.17
Price / Sales	N/A	28.24	556.43	98.84
Price / Cash	N/A	18.86	46.99	54.37
Price / Book	N/A	6.58	10.77	6.35
Net Income	-$2.70M	-$20.39M	$3.57B	$337.63M

Dynatronics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DYNT Dynatronics	N/A	N/A	N/A	N/A	$653K	$33.60M	N/A	200
IVF INVO Fertility	2.3528 of 5 stars	$1.37 -1.4%	$20.00 +1,359.9%	-98.0%	$2.48M	$6.84M	N/A	10	News Coverage Earnings Report Gap Down
BBLG Bone Biologics	1.1779 of 5 stars	$1.38 +0.7%	N/A	-66.3%	$2.46M	N/A	N/A	2	Gap Down
GCTK GlucoTrack	0.5812 of 5 stars	$0.36 +0.1%	N/A	-93.7%	$2.28M	N/A	N/A	5
PTHL Pheton	N/A	$0.32 +2.2%	N/A	-98.2%	$2.11M	$305.22K	N/A	11

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DYNT) was last updated on 6/27/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Dynatronics (DYNT) Competitors

DYNT vs. IVF, BBLG, GCTK, PTHL, and VBIO

How does Dynatronics compare to INVO Fertility?

Summary

How does Dynatronics compare to Bone Biologics?

Summary

How does Dynatronics compare to GlucoTrack?

Summary

How does Dynatronics compare to Pheton?

Summary

How does Dynatronics compare to Valion Bio, Inc. Common Stock?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DYNT vs. The Competition

Dynatronics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Dynatronics (DYNT) Competitors

DYNT vs. IVF, BBLG, GCTK, PTHL, and VBIO

How does Dynatronics compare to INVO Fertility?

Does the media prefer DYNT or IVF?

Which has preferable valuation & earnings, DYNT or IVF?

Do analysts recommend DYNT or IVF?

Is DYNT or IVF more profitable?

Do institutionals and insiders believe in DYNT or IVF?

Which has more volatility & risk, DYNT or IVF?

Summary

How does Dynatronics compare to Bone Biologics?

Do insiders & institutionals believe in BBLG or DYNT?

Does the media favor BBLG or DYNT?

Is BBLG or DYNT more profitable?

Which has higher earnings and valuation, BBLG or DYNT?

Which has more volatility & risk, BBLG or DYNT?

Do analysts rate BBLG or DYNT?

Summary

How does Dynatronics compare to GlucoTrack?

Do institutionals & insiders have more ownership in GCTK or DYNT?

Which has higher valuation & earnings, GCTK or DYNT?

Which has more volatility & risk, GCTK or DYNT?

Is GCTK or DYNT more profitable?

Do analysts prefer GCTK or DYNT?

Does the media refer more to GCTK or DYNT?

Summary

How does Dynatronics compare to Pheton?

Do analysts rate DYNT or PTHL?

Does the media prefer DYNT or PTHL?

Do institutionals & insiders believe in DYNT or PTHL?

Which has more risk and volatility, DYNT or PTHL?

Is DYNT or PTHL more profitable?

Which has better earnings and valuation, DYNT or PTHL?

Summary

How does Dynatronics compare to Valion Bio, Inc. Common Stock?

Does the media favor DYNT or VBIO?

Do analysts recommend DYNT or VBIO?

Which has more risk & volatility, DYNT or VBIO?

Is DYNT or VBIO more profitable?

Do institutionals and insiders hold more shares of DYNT or VBIO?

Which has preferable valuation and earnings, DYNT or VBIO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DYNT vs. The Competition

Dynatronics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools